{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-22-B\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=B\n|Title=Thymoregulators: knowing the indications, non-indications and contra-indications at all stages of life, particularly in patients with Alzheimer's disease.\n|Description=Notably valproic acid and other teratogenic products and women of childbearing age\n|Rubric=Management\n|Contributors=Louise Carton,Florian Naudet,Marie Tournier\n|Ordre=22}}\n\n== Indications\nBipolar disorder, the most common indication :\n\n* Curative treatment of a manic or depressive episode,\n* Treatment to prevent recurrence of mania or depression.\n\n{| class=\"wikitable\"\n|+\n|}\n{| class=\"wikitable\"\n|+\n{| class=\"wikitable\"\n|'''Treatment'''\n|'''Lithium'''\n|'''Carbamazepine''''\n|'''Valpromide'''\n\nValproate\n|Lamotrigine\n|-\n|'''Absolute contraindications'''\n|\n\n\nSevere renal insufficiency\n\nSodium depletion, hyponatremia\n\nSalt-free or low-salt diet\n\nSevere coronary artery disease\n\nCombination with salidiuretics\n\nUnstable heart failure,\n\nBreastfeeding\n|Cardiac conduction disorders (atrioventricular block)\n\nHistory of acute intermittent porphyria\n\nHistory of bone marrow aplasia\n\nKnown hypersensitivity\n\nPregnancy\n|Known hypersensitivity\n\nAcute hepatitis\n\nChronic hepatitis\n\nPersonal or family history of severe hepatitis\n\nHepatic porphyria\n\nAssociation with mefloquine\n\nAssociation with St John's Wort\n\nPregnancy\n|Known hypersensitivity\n|-\n|Relative contraindications\n|Moderate renal impairment\n\nHTA\n\nEpilepsy\n\nHypothyroidism\n\nPregnancy in the 1st trimester\n|Breastfeeding\n\nSevere liver failure\n\nAngle-closure glaucoma\n\nProstate adenoma\n\nWomen of childbearing age\n\n|Association with lamotrigine\n\nBreastfeeding\n\nWomen of childbearing age\n\n|History of allergy to other antiepileptic drugs\n|}\n|'''Class'''\n|Molecules\n|'''Treatment of manic episodes'''\n|'''Treatment of depressive episodes'''\n|'''Treatment to prevent recurrence'''\n|'''Practical aspects'''\n|-\n|'''Lithium salts'''\n|Lithium salts\n|X\n|X\n|X\n|Reference Thymoregulator\n|-\n| rowspan=\"4\" |'''Anticonvulsant thymoregulators''''\n|Valproate\n|X\n|X\n|X\n|1<sup>rst</sup> line\n|-\n|Lamotrigine\n|\n|X\n|X\n|1st line\n|-\n|Valpromide\n|X\n|X\n|X\n|2<sup>of</sup> line\n|-\n|Carbamazepine\n|X\n|\n|X\n|2<sup>of</sup> line\n|}",
  "question": {
    "question": "What is the most common indication for the use of thymoregulators, such as valproic acid?",
    "option_a": "Treatment of anxiety disorders",
    "option_b": "Treatment of bipolar disorder",
    "option_c": "Treatment of attention deficit hyperactivity disorder (ADHD)",
    "option_d": "Treatment of obsessive-compulsive disorder (OCD)",
    "correct_option": "B"
  }
}